Posts Tagged ‘Jennifer Maynard’

“Antibody-like” T Cell Receptors May Be New Potential Treatment for Cytomegalovirus (#CMV) and Brain Tumors

Posted on:
“Antibody-like” T Cell Receptors May Be New Potential Treatment for Cytomegalovirus (#CMV) and Brain Tumors

Texas ChE Professor Jennifer Maynard and her research team have engineered “antibody-like” T cell receptors that can specifically stick to cells infected with cytomegalovirus, or CMV, a virus that causes lifelong infection in more than half of all adults by age 40. These receptors represent a new potential treatment option, could aid the development of Read the rest »

Alum Elected Vice Chair of the BIOTEC Section of the American Association of Pharmaceutical Scientists

Posted on:
Alum Elected Vice Chair of the BIOTEC Section of the American Association of Pharmaceutical Scientists

Alumnus Tarik Khan (Ph.D. ’12) has been elected as the new vice chair of the Biotechnology Section of the American Association of Pharmaceutical Scientists (AAPS). Khan is a former student of the Maynard Lab Group.

“This recognition by his fellow scientists is a testament to the his ongoing contributions and leadership in the pharmaceutical field,” … Read the rest »

Gates Foundation Grant Jump-Starts Innovative Malaria Research at UT Austin

Posted on:

Maynard Group’s Preclinical Findings Bring Whooping Cough Treatment Closer to Human Trials

Posted on:
Maynard Group’s Preclinical Findings Bring Whooping Cough Treatment Closer to Human Trials

Texas ChE researchers recently published preclinical test results showing the use of antibodies in mice and baboons was successful in providing short-term immunity and an accelerated recovery from pertussis, also known as whooping cough. The findings, which were published in a paper on Dec. 2 in Science Translational Medicine, will help advance the treatment … Read the rest »

Top Presenters Announced for the 2014-2015 Graduate Student Seminar Series

Posted on:
Top Presenters Announced for the 2014-2015 Graduate Student Seminar Series

The department is pleased to announce top presenters for this year’s Graduate Student Seminar Series, as voted by attending first-year and third-year Ph.D. students:

Top Presenter
Ben Wendel (Georgiou Group)
A System Immunology Approach to the Development of Natural Immunity to Malaria

Ben’s research explores the progression of the immune system with age … Read the rest »

Jennifer Maynard’s Vaccine Research Showcased at SXSW

Posted on:
Jennifer Maynard’s Vaccine Research Showcased at SXSW

South by Southwest (SXSW) Interactive is hosting inventors, thought leaders and entrepreneurs at the festival’s UT Village Sunday, March 15 from 9:30 a.m.-6 p.m. at the Radisson Hotel & Suites in downtown Austin.

The event is an all-day showcase of innovation and expertise that offers visitors the chance to get a behind-the-scenes look at the … Read the rest »

Jennifer Maynard’s Work to Fight Whooping Cough Featured on National Public Radio

Posted on:
Jennifer Maynard’s Work to Fight Whooping Cough Featured on National Public Radio

Associate professor Jennifer Maynard’s research group is working to develop a therapeutic vaccine to treat whooping cough—a highly contagious and dangerous disease that causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children. Whooping cough is on the rise in the United States, and in Texas cases have increased 79 percent in … Read the rest »

Undergraduate Alex Prybutok’s Whooping Cough Vaccine Poster Places Second At AIChE

Posted on:
Undergraduate Alex Prybutok’s Whooping Cough Vaccine Poster Places Second At AIChE

Undergraduate Alex Prybutok won second place in the Division of Food, Pharmaceuticals, and Biotechnology Poster Competition at the American Institute of Chemical Engineers Annual Meeting in Atlanta.

Alex’s winning poster featured research she is conducting in Dr. Jennifer Maynard’s labto improve therapeutics to fight pertussis, more commonly known as Whooping Cough. Each year … Read the rest »

Finding A Better Way To Fight Whooping Cough

Posted on:

Maynard Teams Up With Synthetic Biologics To Fight Whooping Cough

Posted on:
Maynard Teams Up With Synthetic Biologics To Fight Whooping Cough

Associate Professor Jennifer Maynard, the Laurence E. McMakin, Jr. Centennial Faculty Fellow, has teamed up with biotech company Synthetic Biologics, Inc. to develop a monoclonal antibody (mAb) therapy for the treatment of pertussis, commonly known as whooping cough.

Whooping cough causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children.  Recent reports … Read the rest »